Structures by: Wood P. A.
Total: 150
3-Hydroxysalicylaldoxime
C7H7N1O3
Acta Crystallographica Section E (2007) 63, 7 o3131-o3131
a=13.4603(10)Å b=3.7507(3)Å c=14.8398(11)Å
α=90° β=114.531(5)° γ=90°
3-fluorosalicylaldoxime
C7H6F1N1O2
Acta Crystallographica Section E (2007) 63, 7 o3132-o3132
a=7.0497(3)Å b=10.5161(4)Å c=9.1022(4)Å
α=90° β=90° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section E (2006) 62, 9 o3944-o3946
a=7.6691(2)Å b=12.7162(3)Å c=13.3652(3)Å
α=90° β=90° γ=90°
3-Fluorosalicylaldoxime
C7H6F1N1O2
Acta Crystallographica Section E (2009) 65, 8 o2001
a=6.156(2)Å b=9.751(3)Å c=8.6764(18)Å
α=90° β=90° γ=90°
[Mn6O2(EtSaO)6(EtO)4(PhAc)2(H2O)2].2(EtOH)
[Mn6O2(EtSaO)6(EtO)4(PhAc)2(H2O)2].2(EtOH)
Journal of the American Chemical Society (2007) 129, 1 8-9
a=12.4947(9)Å b=13.2846(9)Å c=14.5047(11)Å
α=71.488(4)° β=82.305(4)° γ=68.687(4)°
[Mn6O2(sal)6(MeOH)4(CHOO)2].2MeOH
[Mn6O2(sal)6(MeOH)4(CHOO)2].2MeOH
Journal of the American Chemical Society (2007) 129, 6547-6561
a=9.3612(3)Å b=12.8616(4)Å c=13.8655(5)Å
α=107.441(2)° β=96.022(2)° γ=95.548(2)°
[Mn6O2(EtSaO)6(EtO)4(PhAc)2(H2O)2].2(EtOH)
[Mn6O2(EtSaO)6(EtO)4(PhAc)2(H2O)2].2(EtOH)
Journal of the American Chemical Society (2007) 129, 6547-6561
a=12.4947(9)Å b=13.2846(9)Å c=14.5047(11)Å
α=71.488(4)° β=82.305(4)° γ=68.687(4)°
C24H24
C24H24
Journal of the American Chemical Society (2007) 129, 13193-13200
a=11.7766(7)Å b=8.3887(5)Å c=53.660(3)Å
α=90° β=90.134(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.564(7)Å b=10.0876(18)Å c=7.6419(12)Å
α=90° β=96.38(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=9.3214(11)Å b=10.5932(12)Å c=7.6988(9)Å
α=90° β=95.059(8)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.868(9)Å b=10.2833(16)Å c=7.7016(13)Å
α=90° β=95.88(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.367(8)Å b=9.9317(17)Å c=7.5667(12)Å
α=90° β=96.49(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.254(4)Å b=9.8542(15)Å c=7.5245(11)Å
α=90° β=96.63(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=7.938(7)Å b=9.754(3)Å c=7.481(2)Å
α=90° β=97.03(6)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.054(7)Å b=9.782(3)Å c=7.5043(19)Å
α=90° β=96.80(5)° γ=90°
Carbamazepine:acidpic acid cocrystal (2:1)
C18H17N2O3
Crystal Growth & Design (2009) 9, 4 1869
a=7.3375(8)Å b=14.7716(17)Å c=15.8886(18)Å
α=69.376(8)° β=84.178(9)° γ=88.266(9)°
Carbamazepine:4-hydroxybenzoic acid cocrystal, form C (1:1)
C15H12N2O,C7H6O3
Crystal Growth & Design (2009) 9, 4 1869
a=13.3059(9)Å b=6.6658(4)Å c=20.7091(14)Å
α=90.00° β=91.0140(10)° γ=90.00°
Carbamazepine host structure with 4-hydroxybenzoic acid removed
C15H12N2O
Crystal Growth & Design (2009) 9, 4 1869
a=20.4438(9)Å b=5.1527(2)Å c=26.5197(12)Å
α=90.00° β=95.264(2)° γ=90.00°
Carbamazepine:glutaric acid cocrystal (1:1)
C20H20N2O5
Crystal Growth & Design (2009) 9, 4 1869
a=18.5619(10)Å b=5.1201(3)Å c=19.4588(9)Å
α=90.00° β=106.839(3)° γ=90.00°
Carbamazepine host structure with malonic acid removed
C15H12N2O
Crystal Growth & Design (2009) 9, 4 1869
a=10.3327(15)Å b=26.611(5)Å c=5.0875(9)Å
α=90.00° β=104.258(9)° γ=90.00°
Carbamazepine:salicylic acid cocrystal (1:1)
C22H18N2O4
Crystal Growth & Design (2009) 9, 4 1869
a=5.1064(6)Å b=19.783(2)Å c=18.328(2)Å
α=90.00° β=97.903(7)° γ=90.00°
Carbamazepine host structure with DL-tartaric acid removed
C15H12N2O
Crystal Growth & Design (2009) 9, 4 1869
a=10.3006(9)Å b=26.972(2)Å c=5.0718(4)Å
α=90.00° β=104.235(6)° γ=90.00°
Carbamazepine:1-hydroxy-2-naphthoic acid cocrystal (1:1)
C26H20N2O4
Crystal Growth & Design (2009) 9, 4 1869
a=16.6411(13)Å b=5.0526(5)Å c=24.493(2)Å
α=90.00° β=99.062(6)° γ=90.00°
Carbamazepine host structure with maleic acid removed
C15H12N2O
Crystal Growth & Design (2009) 9, 4 1869
a=10.4207(14)Å b=26.168(4)Å c=5.2089(7)Å
α=90.00° β=104.346(9)° γ=90.00°
Carbamazepine host structure with oxalic acid removed
C15H12N2O
Crystal Growth & Design (2009) 9, 4 1869
a=10.330(14)Å b=26.24(3)Å c=5.110(6)Å
α=90.00° β=104.21(3)° γ=90.00°
Carbamazepine:(+)-camphoric acid cocrystal (1:1)
C25H28N2O5
Crystal Growth & Design (2009) 9, 4 1869
a=12.5885(6)Å b=13.1453(6)Å c=14.4820(7)Å
α=90.00° β=105.745(2)° γ=90.00°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
CrystEngComm (2008) 10, 2 239
a=12.748(2)Å b=3.5954(3)Å c=13.6496(15)Å
α=90° β=93.115(13)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.2791(7)Å b=4.7643(3)Å c=17.9649(17)Å
α=90° β=93.960(4)° γ=90°
Nonylamine
C9H21N1
CrystEngComm (2014) 16, 19 3867
a=5.5458(2)Å b=50.6527(17)Å c=7.0521(2)Å
α=90° β=90.040(2)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=9.851(3)Å b=4.9325(7)Å c=12.286(3)Å
α=90° β=111.09(2)° γ=90°
[Mn6(EtSaO)6(EtOH)5(Piv)2]
[Mn6(EtSaO)6(EtOH)5(Piv)2]
Journal of the American Chemical Society (2007) 129, 6547-6561
a=13.486(3)Å b=14.882(3)Å c=20.822(4)Å
α=82.87(3)° β=85.73(3)° γ=76.51(3)°
Carbamazepine:benzoic acid cocrystal (1:1)
C22H18N2O3
Crystal Growth & Design (2009) 9, 4 1869
a=28.5185(18)Å b=5.1607(4)Å c=24.7363(15)Å
α=90.00° β=103.448(4)° γ=90.00°
Carbamazepine:4-hydroxybenzoic acid cocrystal, form A (1:1)
C22H18N2O4
Crystal Growth & Design (2009) 9, 4 1869
a=7.0994(3)Å b=12.7087(6)Å c=20.1105(9)Å
α=90.00° β=91.870(2)° γ=90.00°
C11H15NO2
C11H15NO2
Inorganic Chemistry (2011) 50, 4515-4522
a=8.5221(4)Å b=10.7421(5)Å c=11.6515(6)Å
α=90.00° β=90.00° γ=90.00°
C15H23NO2
C15H23NO2
Inorganic Chemistry (2011) 50, 4515-4522
a=12.1513(3)Å b=8.1802(2)Å c=15.2351(4)Å
α=90.00° β=106.752(2)° γ=90.00°
C12H17NO3
C12H17NO3
Inorganic Chemistry (2011) 50, 4515-4522
a=9.6192(4)Å b=10.6124(4)Å c=11.8069(5)Å
α=90.00° β=90.00° γ=90.00°
C15H23N1O2
C15H23N1O2
Inorganic Chemistry (2011) 50, 4515-4522
a=12.5153(8)Å b=8.0997(5)Å c=14.0564(8)Å
α=90.00° β=96.496(4)° γ=90.00°
C7H6BrNO2
C7H6BrNO2
Inorganic Chemistry (2011) 50, 4515-4522
a=13.2519(4)Å b=3.96160(10)Å c=14.4954(5)Å
α=90.00° β=91.832(2)° γ=90.00°
C12H17NO2
C12H17NO2
Inorganic Chemistry (2011) 50, 4515-4522
a=9.4523(6)Å b=9.6626(5)Å c=25.5013(15)Å
α=90.00° β=90.00° γ=90.00°
C11H14N2O4
C11H14N2O4
Inorganic Chemistry (2011) 50, 4515-4522
a=5.9763(2)Å b=7.3363(3)Å c=13.4872(5)Å
α=80.545(2)° β=80.030(2)° γ=86.569(2)°
C15H22N2O4
C15H22N2O4
Inorganic Chemistry (2011) 50, 4515-4522
a=7.0554(6)Å b=13.7741(13)Å c=8.3130(5)Å
α=91.144(6)° β=106.331(6)° γ=89.509(7)°
C66H84Cu3N6O12
C66H84Cu3N6O12
Inorganic Chemistry (2011) 50, 4515-4522
a=10.3884(5)Å b=10.3905(5)Å c=18.9956(9)Å
α=77.787(3)° β=83.298(3)° γ=60.492(2)°
C30H44CuN2O4
C30H44CuN2O4
Inorganic Chemistry (2011) 50, 4515-4522
a=31.7417(14)Å b=8.3449(4)Å c=16.3194(7)Å
α=90.00° β=90.035(3)° γ=90.00°
C24H32CuN2O4
C24H32CuN2O4
Inorganic Chemistry (2011) 50, 4515-4522
a=18.6883(2)Å b=18.6883Å c=13.3732(2)Å
α=90.00° β=90.00° γ=90.00°
C32H36CuN6O8
C32H36CuN6O8
Inorganic Chemistry (2011) 50, 4515-4522
a=8.7844(4)Å b=13.1827(7)Å c=14.3481(8)Å
α=79.250(4)° β=77.374(4)° γ=82.427(4)°
C22H26Br2CuN2O4
C22H26Br2CuN2O4
Inorganic Chemistry (2011) 50, 4515-4522
a=5.8093(4)Å b=8.9279(6)Å c=12.0867(9)Å
α=71.499(5)° β=82.942(5)° γ=72.686(5)°
C24H32CuN2O6
C24H32CuN2O6
Inorganic Chemistry (2011) 50, 4515-4522
a=17.7657(9)Å b=20.8218(11)Å c=6.5914(4)Å
α=90.00° β=96.641(3)° γ=90.00°
C11H14ClNO2
C11H14ClNO2
Inorganic Chemistry (2011) 50, 4515-4522
a=13.5893(6)Å b=13.6734(6)Å c=25.0498(10)Å
α=89.985(3)° β=99.204(3)° γ=89.986(3)°
C11H14BrNO2
C11H14BrNO2
Inorganic Chemistry (2011) 50, 4515-4522
a=13.8459(4)Å b=13.9486(4)Å c=24.8103(7)Å
α=90.00° β=99.796(2)° γ=90.00°
R-(+)-2-bromo-alpha-methyl benzylalcohol
C8H9BrO
Zeitschrift für Kristallographie - New Crystal Structures (2009) 224, 1 119
a=7.3240(13)Å b=11.946(2)Å c=19.336(4)Å
α=90.00° β=90.00° γ=90.00°